FDA Clears AI Tool to Spot Cardiovascular Disease Risk Ahead of Symptoms
A first-of-its-kind AI tool was cleared by the FDA to detect underlying structural heart disease before symptoms present. ljubaphoto/Getty Images The FDA cleared the first artificial intelligence tool to detect hidden structural heart di…
Sourcing & attribution. Newseze provides AI-curated summaries, narrative framing, and editorial analysis. The underlying reporting was contributed by Healthline; tap “Open original source” above to read their full reporting and support the contributing newsroom directly.
Newseze's algorithm reads the story and answers your question — calmly, factually, with source attribution. No comments, no flame wars — just answers.
No questions yet. Be the first.
Answers reflect Newseze's editorial framework applied under fair use (17 U.S.C. § 107). Not financial, legal, medical, or tax advice. Hate speech and racial slurs are blocked.
Related stories
Why it mattersA study on COVID-19 vaccines that was previously blocked by the CDC’s acting director was published in a medical journal. luis velasco/Stocksy A COVID-19 vaccine efficacy study that had previously been blocked by the CDC…
A study on COVID-19 vaccines that was previously blocked by the CDC’s acting director was published in a medical journal. luis velasco/Stocksy A COVID-19 vaccin…
By Chella·17h ago
Why it mattersFor chronic dieters stuck in yo-yo cycles, intermittent fasting may offer both weight loss and relief from constant food thoughts—suggesting the structure itself, not just calories, shapes eating behavior.
Researchers compared intermittent fasting with calorie counting and found that people following fasting protocols thought about food less often. Anchiy/Getty Im…
By Chella·1d ago
Why it mattersAn estimated 14 million Medicare Part D recipients could obtain Wegovy, Foundayo, and Zepbound for $50 per month. Johner Images/Getty Images Federal officials announced the launch of a Medicare GLP-1 Bridge pilot program…
An estimated 14 million Medicare Part D recipients could obtain Wegovy, Foundayo, and Zepbound for $50 per month. Johner Images/Getty Images Federal officials a…
By Chella·7h ago
Why it mattersGLP-1 drugs can provide benefits that may boost an athlete’s performance, but do these medications give them the competitive edge? Getty Images/The Good Brigade Debates are emerging over whether GLP-1 drugs boost athleti…
GLP-1 drugs can provide benefits that may boost an athlete’s performance, but do these medications give them the competitive edge? Getty Images/The Good Brigade…
By Chella·17h ago